The decrease in peripheral fat was present despite increased food intake after 6 weeks of LJP305 treatment and was associated with a strong trend of reduction in circulating leptin levels (35% vs. vehicle) (Fig. 5 F).
← all excerpts
Farnesoid X Receptor Agonism, Acetyl-Coenzyme A Carboxylase Inhibition, and Back Translation of Clinically Observed Endpoints of <i>De Novo</i> Lipogenesis in a Murine NASH Model.
1
—
—